Editorial Volume 11, Issue 20 pp 8743—8744
CD38-NAD+-Sirt1 axis in T cell immunotherapy
- 1 Indian Institute of Chemical Biology, TRUE Campus, Kolkata 700091, India
- 2 Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA
received: June 24, 2019 ; published: October 23, 2019 ;https://doi.org/10.18632/aging.102385
How to Cite
Copyright © 2019 Chatterjee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.